The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients
D. Klein (Copenhagen, Denmark), T. Lapperre (Copenhagen, Denmark), U. Bødtger (Næstved, Denmark), K. Romberg (Höllviken, Sweden), L. Bjermer (Lund, Sweden), J. Erjefält (Lund, Sweden), K. Kristiansen (Copenhagen, Denmark), C. Porsbjerg (Copenhagen, Denmark)
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Session: Monitoring of inflammation in remodelling
Session type: E-poster session
Number: 3320
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Klein (Copenhagen, Denmark), T. Lapperre (Copenhagen, Denmark), U. Bødtger (Næstved, Denmark), K. Romberg (Höllviken, Sweden), L. Bjermer (Lund, Sweden), J. Erjefält (Lund, Sweden), K. Kristiansen (Copenhagen, Denmark), C. Porsbjerg (Copenhagen, Denmark). The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients. 3320
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Same role and same treatment for airway eosinophilia in asthma and COPD? Source: Eur Respir J 2007; 29: 831-833 Year: 2007
Heterogeneous response of airway eosinophilia to biologics in severe asthma patients Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021
Neutrophilic inflammation in severe asthmatics and COPD patients with the same severity of airway obstruction Source: Eur Respir J 2002; 20: Suppl. 38, 505s Year: 2002
Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009
Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD Source: Eur Respir J 2013; 41: 993-995 Year: 2013
The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013
Add-on omalizumab therapy reduces clinically significant and severe asthma exacerbations, and improves FEV1 in patients with severe persistent allergic asthma irrespective of age Source: Eur Respir J 2005; 26: Suppl. 49, 48s Year: 2005
Dupilumab improves lung function and reduces severe exacerbations in uncontrolled persistent asthma patients with ongoing allergic rhinitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017
Current control, airway inflammation, and subsequent exacerbation in patients with asthma Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010
Maximal airway response in patients with asthma and cough variant asthma Source: Annual Congress 2007 - COPD, sarcoidosis, idiopathic pulmonary fibrosis, cystic fibrosis, gastro-oesophageal reflux and cough variant asthma - pathogenesis and differential diagnosis Year: 2007
COPD patients with asthma, characteristics and risk of exacerbations Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019
The effect of bronchiectasis on asthma exacerbations Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012
Tiotropium improved asthma symptoms and increased time to first exacerbation in patients with moderate-to-severe asthma. Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights Year: 2020
COPD and asthma overlap with bronchiectasis Source: Eur Respir Monogr 2018; 81: 167-185 Year: 2018
Localization of respiratory viral antigens in patients with exacerbations of non allergic late-onset asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 411s Year: 2004
Small airways disease evaluation in patients with mild/moderate asthma and correlation with bronchial hyperresponsiveness and disease control Source: International Congress 2018 – Clinical and functional monitoring in airway disease Year: 2018
Tiotropium reduces asthma exacerbations in asthmatic patients with persistent airflow obstruction uncontrolled despite treatment in accordance with guidelines Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma Year: 2012
Factors driving airway eosinophilia in prednisone-dependent severe asthma Source: International Congress 2017 – Pathophysiology and emerging therapies for severe asthma Year: 2017
Systemic and airway inflammation and the presence of emphysema in patients with COPD Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009